ERIC BRANDT

CIK 1190639 · Former EVP & CFO · last filed 2026-06-15

ERIC BRANDT is a Former EVP & CFO who has filed 243 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing shows the insider sold $20.0M of LRCX on Jun 15, 2026. Across all open-market trades the lifetime net is −$81.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $60.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$60.81M

Companies

11

Total Filings

243

Lifetime Open-Market Net

-$81.82M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LRCX Director 216,356 $255.75 $55.33M -$47.03M 22 2026-06-15
OPCH Director 21,999 $24.09 $530.1K $0 3 2026-05-22
NTNX Director 6,698 $59.48 $398.4K $0 2 2025-12-16
GENVR Director 88,544 $1.80 $159.5K $0 1 2025-09-11
GEN Director 69,684 $27.57 $1.92M $0 3 2024-09-13
MAC Director 62,978 $25.96 $1.64M $0 8 2024-06-03
XRAY Director 58,772 $14.12 $829.6K -$2.48M 58 2024-04-15
Gen Digital Inc. (NLOK) Delisted Director 46,306 $21.66 $1.00M $0 5 2022-09-23
BROADCOM CORP (BRCM) Delisted Executive Vice President & CFO 490,984 -$31.40M 53 2015-12-14
VRTX Director 0 $483.44 $0 -$907.5K 3 2009-01-30
AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted President, CEO & Director 351,482 $0 1 2007-03-07

Recent Filings

243 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-15 LRCX Sell (S) −54,500 -$20.01M EDGAR
2026-06-15 LRCX Sell (S) −54,500 -$19.12M EDGAR
2026-06-12 LRCX Notice (144) −54,500 -$19.59M EDGAR
2026-06-11 LRCX Notice (144) −54,500 -$19.12M EDGAR
2026-05-22 OPCH Grant (A) +11,640 $58.8K EDGAR
2026-02-09 LRCX Sell (S) −35,000 -$7.90M EDGAR
2026-02-06 LRCX Notice (144) −35,000 -$7.90M EDGAR
2025-12-16 NTNX Grant (A) +4,588 $0 EDGAR
2025-11-10 LRCX Grant (A) +1,635 $0 EDGAR
2025-09-11 GENVR Mixed +8,822 $0 EDGAR
Showing 110 of 243
Page 1 of 25
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.